Detalhe da pesquisa
1.
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
N Engl J Med
; 390(12): 1080-1091, 2024 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38507751
2.
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 380(8): 741-751, 2019 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30786188
3.
Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment.
Br J Clin Pharmacol
; 88(7): 3392-3403, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35236002
4.
Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors.
Anticancer Drugs
; 30(5): 523-532, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30875341
5.
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2- early breast cancer.
Ther Adv Med Oncol
; 15: 17588359231178125, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37275963
6.
Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study.
Lancet Oncol
; 12(4): 369-76, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21429799
7.
Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood.
PLoS One
; 17(6): e0264651, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35749519
8.
Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy.
Int J Breast Cancer
; 2017: 1367159, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29147583
9.
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.
J Clin Oncol
; 35(19): 2141-2148, 2017 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28291390
10.
Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery.
Ann Thorac Surg
; 75(1): 17-22, 2003 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-12537186
11.
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.
J Clin Oncol
; 32(32): 3626-33, 2014 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-25287822
12.
A phase II trial of docetaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (TORI B01).
Clin Breast Cancer
; 10(4): 307-12, 2010 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20705564